Minimum Anaesthesia Concentration of Lidocaine Required for Sciatic Popliteal Block
NCT ID: NCT03613974
Last Updated: 2018-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
50 participants
INTERVENTIONAL
2018-12-15
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve Block
NCT04397484
Sciatic Block in Contralateral Limb Phantom and Residual Limb Pain
NCT05046639
A Study of Contralateral Limb Block
NCT06045936
Adductor Canal Nerve Block Following Total Knee Arthroplasty
NCT01939379
The Effect of PPB Using 10, 20 and 30 ml of Lidocaine, Study on Volunteers
NCT05464862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lidocaine concentraion
the popliteal block will be performed (once) in all patients using 20 ml of lidoacine. The response of a patient determined the lidocaine concentration given to the next patient (a biased-coin design up-down sequential method). If a patient had a negative response (failed block), the lidocaine concentration was increased by 0.1% w/v in the next patient. If a patient had a positive response (successful block), the next patient was randomized to receive the same lidocaine concentration (with probability of 0.89), or to receive a concentration 0.1% w/v less (with probability of 0.11).
Lidocaine
patients will receive different lidocaine concentrations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine
patients will receive different lidocaine concentrations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* day case surgery
Exclusion Criteria
* ASA class greater \>III,
* obese (BMI \>30),
* patients with low body weight, who required lidocaine dose is of more than 4.5mg.kg-1
* peripheral neuropathy,
* motor weakness,
* infection at the injection site
* any contraindications for medications in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Healthpoint Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmad Muhammad Taha
Consultant of anesthesia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Healthpoint Hospital
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.